Items Tagged ‘Food and Drug Administration’

September 26, 2013

Mayo Clinic in the News Weekly Highlights

By Karl W Oestreich KarlWOestreich

    September 27, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]

View full entry

Tags: ABC News, ABCnews.com, Affordable care act, Arizona State University, ASU Insight, Batman, blood biomarker, Bob Nellis, Breast Cancer, CDC, Chris Gade, CNBC


February 22, 2013

Mayo Clinic in the News Weekly Highlights

By Karl W Oestreich KarlWOestreich

    February 22, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]

View full entry

Tags: American Gastroenterological Association, Barrett's esophagus, Cannon Falls, Cannon Falls Beacon, cardiovascular surgery, chronic acid reflux, Controlled Substances Act, Decade of Discovery, destination medical center, DMC, Dr. Bradly Narr, Dr. C. Daniel Smith


July 10, 2012

FDA Panel Supports Continued Testing of Pain Drugs

By

A panel of arthritis experts recommended Monday that the federal government allow continued testing of an experimental class of pain drugs for arthritis, despite links to bone decay and joint failure. The Food and Drug Administration’s 21-member panel of arthritis experts voted unanimously that research on the nerve-blocking drugs should continue, with certain safety precautions. […]

View full entry

Tags: Dr. Sherine Gabriel, Food and Drug Administration


June 15, 2012

Mayo Clinic in the News Weekly Highlights

By

June 15, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations NY […]

View full entry

Tags: Chicago Tribune, Dr. Chet Rihal, Dr. David Hayes, Dr. Dennis Dickson, Dr. John Armstrong, Dr. Sharonne Hayes, Fairview Red Wing Health Services, Food and Drug Administration, Good Morning Arizona, Jacksonville Business Journal, Lawrence Matteson, Marylin Matteson


June 11, 2012

New Drug Can Fight Inherited Skin Cancer

By

There is a new drug to fight skin cancer for the sun-splashed masses of Arizona. The drug, vismodegib, was approved by the Food and Drug Administration in January for people with an advanced form of one type of skin cancer, basal-cell carcinoma. New research unveiled last week by local doctors and other scientists shows that […]

View full entry

Tags: Aleksander Sekulic, Arizona Republic, carcinoma, Food and Drug Administration, New England Journal of Medicine, skin cancer


April 17, 2012

Another Amyloid Tracer Shows Promise in Alzheimer’s

By

On the heels of the US Food and Drug Administration (FDA) approval of the amyloid tracer agent florbetapir (Amyvid, Eli Lilly), another biomarker is showing promise in detecting beta-amyloid deposition in the brains of living patients…Asked for his opinion, David Knopman, MD, Department of Neurology, Mayo Clinic, Rochester, Minnesota, said he found the accuracy of […]

View full entry

Tags: Dr. David Knopman, florbetapir, Food and Drug Administration


February 23, 2012

FDA to review safety of caffeine product

By

Food and Drug Administration officials plan to investigate whether a form of caffeine sold in lipstick-shaped containers is safe for consumers. The inventor touts AeroShot as caffeine without the coffee, soda, tea or a pill, but a U.S. lawmaker questions whether it’s safe…”For most healthy adults, moderate doses of caffeine — 200mg to 300mg, or […]

View full entry

Tags: AeroShot, Food and Drug Administration, lipstick-shaped containers of caffeine


February 9, 2012

FDA panel votes against Xgeva for prostate cancer

By

panel of cancer experts voted against a new use for Amgen’s Xgeva in prostate cancer on Wednesday, saying the drug’s ability to slow the spread of the disease did not translate into meaningful benefits for patients.The Food and Drug Administration’s cancer drug panel voted 12-1 that the benefits of the drug did not outweigh its […]

View full entry

Tags: amgen, cancer drug panel, Dr. Ronald Richardson, FDA, Food and Drug Administration, prostate cancer, Xgeva


Contact Us · Privacy Policy